BullFrog AI Appoints New CMO and CSO

Ticker: BFRGW · Form: 8-K · Filed: Dec 12, 2024 · CIK: 1829247

Bullfrog Ai Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyBullfrog Ai Holdings, Inc. (BFRGW)
Form Type8-K
Filed DateDec 12, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.00001
Sentimentneutral

Sentiment: neutral

Topics: executive-appointment, board-of-directors, personnel-change

Related Tickers: BFRG

TL;DR

BullFrog AI beefs up leadership with new CMO & CSO appointments.

AI Summary

BullFrog AI Holdings, Inc. announced on December 7, 2024, changes in its executive team and board of directors. The company appointed Dr. Sudip Nanda as Chief Medical Officer and a member of the Board of Directors, and Dr. David H. Freeman as Chief Scientific Officer. These appointments are effective immediately and aim to bolster the company's scientific and medical leadership.

Why It Matters

The appointment of experienced medical and scientific officers like Dr. Nanda and Dr. Freeman could accelerate BullFrog AI's drug discovery and development pipeline, potentially leading to significant advancements in their therapeutic areas.

Risk Assessment

Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding strategic direction and operational execution.

Key Players & Entities

  • BullFrog AI Holdings, Inc. (company) — Registrant
  • Dr. Sudip Nanda (person) — Appointed Chief Medical Officer and Board Member
  • Dr. David H. Freeman (person) — Appointed Chief Scientific Officer
  • December 7, 2024 (date) — Effective date of appointments

FAQ

What are the specific qualifications of Dr. Sudip Nanda and Dr. David H. Freeman for their new roles?

The filing states that Dr. Nanda and Dr. Freeman have been appointed to their respective roles, but does not detail their specific qualifications within this document.

What is the effective date of these appointments?

The appointments of Dr. Sudip Nanda and Dr. David H. Freeman are effective immediately as of December 7, 2024.

Are there any changes to the compensation arrangements for these new officers?

The filing mentions 'Compensatory Arrangements of Certain Officers' as an item, but the specific details of compensation for the newly appointed officers are not provided in the excerpt.

What is BullFrog AI Holdings, Inc.'s primary business?

BullFrog AI Holdings, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).

Where is BullFrog AI Holdings, Inc. headquartered?

BullFrog AI Holdings, Inc. is headquartered at 325 Ellington Blvd, Unit 317, Gaithersburg, MD 20878.

Filing Stats: 501 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-12-12 16:15:33

Key Financial Figures

  • $0.00001 — ch registered Common Stock, par value $0.00001 per share BFRG The Nasdaq Stock M

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2024 BULLFROG AI HOLDINGS, INC. (Exact name of Registrant as specified in its charter) Nevada 001-41600 84-4786155 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 325 Ellington Blvd , Unit 317 Gaithersburg , MD 20878 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (240) 658-6710 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.00001 per share BFRG The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Tradeable Warrants BFRGW The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Bullfrog AI Holdings, Inc. (the "Company") deeply regrets to announce that Dane Saglio, the Company's Chief Financial Officer, passed away on December 7, 2024. Mr. Saglio served as the Company's Chief Financial Officer since September 2021. Mr. Saglio was a valued member of the Company's executive management team and will be greatly missed. The Board of Directors of the Company has already conducted a search for a replacement as part of its succession planning and plans to announce a new Chief Financial Officer soon. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibit is being furnished herein: 104 Cover Page Interactive Data File (formatted as Inline XBRL) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 12, 2024 Bullfrog AI Holdings, Inc. By: /s/ Vininder Singh Name: Vininder Singh Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.